Morton Hyson
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,805 and has fallen 91.9% since, to $146 in 2022.
Across 140 payments — averaging $25.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$795
- Acadia Pharmaceuticals Inc$628
- Novartis$384
- UCB, Inc.$327
- SK Life Science, Inc.$240
- Amgen$191
- plus $975 from 22 others
What the payments were for
- Speaking & faculty fees$170%
- Food & beverage$3,50799%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 27 | $795 |
| Acadia Pharmaceuticals Inc | 9 | $628 |
| Novartis | 19 | $384 |
| UCB, Inc. | 17 | $327 |
| SK Life Science, Inc. | 7 | $240 |
| Amgen | 11 | $191 |
| EMD Serono, Inc. | 4 | $171 |
| AbbVie(2 entities) | 8 | $149 |
| Sanofi | 8 | $145 |
| Sunovion Pharmaceuticals Inc. | 4 | $87 |
| Biohaven Pharmaceuticals, Inc. | 3 | $61 |
| Mallinckrodt Enterprises LLC | 2 | $43 |
| Banner Life Sciences, LLC | 2 | $36 |
| Neurelis, Inc. | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $26 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Adamas Pharmaceuticals, Inc. | 1 | $18 |
| Acorda Therapeutics, Inc | 1 | $17 |
| Promius Pharma LLC | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Travere Therapeutics, Inc. | 3 | $16 |
| Forte Bio-pharma LLC | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Bayer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,539 in reported general payments places this provider in the 60th percentile of 145 neurology providers in Nevada.
Other neurology in Lv
- Melissa BlochReno$883K
- Zoltan MariLas Vegas$629K
- Fan ZhangLas Vegas$398K
- le HuaLas Vegas$385K
- Mehdi AnsariniaLas Vegas$306K
- Burton TabaacReno$287K
- Carrie HershLas Vegas$209K
- Shanker DixitLas Vegas$137K
- G BigleyReno$133K
- Charles KamenLas Vegas$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.